The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 06, 2025
Filed:
Oct. 17, 2019
Applicants:
Biolinerx Ltd., Modiln, IL;
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Inventors:
Abi Vainstein-Haras, Herzliya, IL;
Ella Sorani, Kadima, IL;
Irit Gliko-Kabir, Modiln, IL;
Osnat Bohana-Kashtan, Tel-Mond, IL;
Amnon Peled, Tel-Aviv, IL;
Assignees:
BioLineRx Ltd., Modiln, IL;
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2005.12); A61K 31/513 (2005.12); A61K 38/12 (2005.12); A61K 39/00 (2005.12); A61K 45/06 (2005.12); A61P 35/00 (2005.12);
U.S. Cl.
CPC ...
C07K 16/2818 (2012.12); A61K 31/513 (2012.12); A61K 45/06 (2012.12); A61P 35/00 (2017.12); A61K 38/12 (2012.12); A61K 2039/505 (2012.12); A61K 2039/545 (2012.12);
Abstract
A method of treating metastatic pancreatic adenocarcinoma in a subject in need thereof is provided. The method comprising administering to the subject a therapeutically effective amount of each of a peptide set forth in SEQ ID NO: 1, an anti PD-1 and a chemotherapy, thereby treating the metastatic pancreatic adenocarcinoma.